Former Theranos Patients Speak Out
See how ABC are framing this — we run every side, so you decide. News for humans, not bots: serious, civil discussion among real people, with the context and facts you need. Don't just watch: be on the air with your own video takes, polls and predictions.
EVERY NETWORK'S FRAMING
Watch the moment
Add your voice
This storyWhat was the name of the blood-testing device Theranos developed?
- Edison
- Tesla
- Newton
- Franklin
Guess, then reveal the answer
Edison
Theranos sold blood tests to ordinary patients, not just to investors and partners.
Theranos offered tests to the public through Walgreens locations in Arizona and California, and former patients say unreliable results shaped real medical decisions.
The Wall Street Journal's 2015 reporting by John Carreyrou began Theranos' unraveling.
Carreyrou's October 2015 articles questioned whether Theranos' technology worked as claimed, setting off regulatory scrutiny that ended with the company shutting down in 2018.
Theranos' collapse helped push the FDA to tighten lab-test oversight talk.
Theranos ran tests in a CLIA-certified lab, which CMS inspects. Its 2015 inspection failures led to a 2016 ban on Elizabeth Holmes. Congress has since debated VALID Act reforms, but it has not passed.
Topic poll · all networksAfter Holmes' 11-year sentence, what should Theranos' legacy change most?
Theranos was once valued at $9 billion, but Holmes' stake was never cash.
At its 2014 peak, Theranos' $9B valuation made Holmes' roughly 50% stake look worth about $4.5B on paper. Forbes put her net worth at $4.5B, then revised it to zero in 2016 once the technology was questioned.